|
End-of-day quote
Taiwan S.E.
02/10/2026
|
5-day change | 1st Jan Change | ||
| 48.10 TWD | -1.84% |
|
+0.10% | -18.89% |
| Market Cap | 578.43Cr 18Cr 16Cr 15Cr 14Cr 26Cr 1.75TCr 26Cr 182.23Cr 71Cr 892.38Cr 68Cr 67Cr 2.86TCr | P/E 2024 |
52.9x | P/E 2025 | 16.3x |
|---|---|---|---|---|---|
| Enterprise Value | 689.97Cr 22Cr 19Cr 18Cr 16Cr 31Cr 2.08TCr 31Cr 217.37Cr 84Cr 1.06TCr 81Cr 80Cr 3.42TCr | EV / Sales 2024 |
2x | EV / Sales 2025 | 1.7x |
| Free-Float |
78.86% | Yield 2024 |
4.36% | Yield 2025 | 5.06% |
| 1 day | -1.84% | ||
| 1 week | +0.10% | ||
| Current month | -1.74% | ||
| 1 month | -1.33% | ||
| 3 months | -10.43% | ||
| 6 months | -14.11% | ||
| Current year | -18.89% |
| 1 week | 47.45 |  | 49.3 |
| 1 month | 45 | | 49.6 |
| Current year | 45 | | 62.5 |
| 1 year | 45 | | 68.6 |
| 3 years | 45 | | 121 |
| 5 years | 44.2 | | 121 |
| 10 years | 29.75 | | 121 |
| Manager | Title | Age | Since |
|---|---|---|---|
Cheng Yue Cheng
CEO | Chief Executive Officer | - | 01/01/1996 |
Yue Chen Lo
DFI | Director of Finance/CFO | - | 14/04/2003 |
Chin Yuan Lin
IRC | Investor Relations Contact | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Cheng Yue Cheng
CHM | Chairman | - | 01/01/1996 |
Che Jen Chuang
BRD | Director/Board Member | - | 18/06/2012 |
Hung Min Hsieh
BRD | Director/Board Member | - | 28/08/2006 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.84% | +0.10% | -27.56% | -45.15% | 18Cr | |
| -0.61% | -3.43% | +39.40% | +112.31% | 1,02500Cr | |
| -1.02% | -5.60% | +37.67% | +65.02% | 62TCr | |
| +1.11% | -0.58% | +11.10% | +77.28% | 46TCr | |
| +0.34% | -3.01% | +61.21% | +40.71% | 35TCr | |
| -0.95% | -4.87% | +22.46% | +38.03% | 34TCr | |
| -1.46% | -2.20% | +11.84% | +23.94% | 27TCr | |
| -1.35% | -4.27% | -4.55% | +6.92% | 25TCr | |
| -1.04% | -2.79% | +35.52% | +51.34% | 22TCr | |
| -1.87% | -4.10% | +30.92% | +95.33% | 18TCr | |
| Average | -0.81% | -1.69% | +21.80% | +46.57% | 37.18TCr | |
| Weighted average by Cap. | -0.46% | -2.11% | +30.60% | +68.65% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 473.1Cr 15Cr 13Cr 12Cr 11Cr 21Cr 1.43TCr 21Cr 149.05Cr 58Cr 729.88Cr 56Cr 55Cr 2.34TCr | 485.14Cr 15Cr 14Cr 13Cr 12Cr 22Cr 1.46TCr 22Cr 152.84Cr 59Cr 748.44Cr 57Cr 56Cr 2.4TCr |
| Net income | 16Cr 49.37L 43.87L 40.94L 37.32L 70.38L 47Cr 71.03L 4.95Cr 1.92Cr 24Cr 1.85Cr 1.81Cr 78Cr | 44Cr 1.38Cr 1.23Cr 1.15Cr 1.05Cr 1.97Cr 133.12Cr 1.99Cr 14Cr 5.38Cr 68Cr 5.2Cr 5.09Cr 218.4Cr |
| Net Debt | 119.6Cr 3.75Cr 3.34Cr 3.11Cr 2.84Cr 5.35Cr 360.92Cr 5.4Cr 38Cr 15Cr 184.51Cr 14Cr 14Cr 592.15Cr | 111.54Cr 3.5Cr 3.11Cr 2.9Cr 2.65Cr 4.99Cr 336.62Cr 5.04Cr 35Cr 14Cr 172.08Cr 13Cr 13Cr 552.28Cr |
Employees
-
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 02/26/02 | NT$48.10 | -1.84% | 6,74,570 |
| 01/26/01 | NT$49.00 | +0.10% | 4,44,421 |
| 30/26/30 | NT$48.95 | +2.62% | 10,19,870 |
| 29/26/29 | NT$47.70 | -0.73% | 8,73,374 |
| 24/26/24 | NT$48.05 | -1.23% | 6,44,992 |
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 4746 Stock
Select your edition
All financial news and data tailored to specific country editions
